ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Dole to Press HCFA On Community DRG Exemptions, Calls For Meeting TO Assess Problems

March 16, 1984

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Timeline Pinpoints the Role of Cancer Scandal In a Progression Leading to Perry’s Indictment

September 5, 2014

FDA Committee nixes Combination Guidelines, Okays New NDA Policy

January 21, 1977

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

In Brief: John Young to Leave NCI for ELM; Yates Looking for Chief Of Outpatient Services At RPI

March 18, 1988